Revista de Ciências da Saúde

  • ISSN: 1108-7366
  • Índice h do diário: 51
  • Pontuação de citação de diário: 10.69
  • Fator de impacto do periódico: 9.13
Indexado em
  • Genamics JournalSeek
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • CINAHL Completo
  • Scimago
  • Biblioteca de periódicos eletrônicos
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • EMCare
  • OCLC- WorldCat
  • Comissão de Bolsas Universitárias
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
Compartilhe esta página

Abstrato

N-linked Glycosylation and its Potential Application in Drug Development

Shilei Wang, Quanyong He, Jinlei Ye, Zhichao Kang, Qiping Zheng, Shuo Liu, Jun He and Lichun Sun

Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).